Background: WU and KI are human polyomaviruses initially detected in the respiratory tract, whose clinical significance remains uncertain. Objectives: To determine the epidemiology, viral load and clinical characteristics of WU and KI polyomaviruses. Study design: We tested respiratory specimens collected during a randomized, placebo-controlled pneumococcal conjugate vaccine trial and related epidemiological study in the Philippines. We analyzed 1077 nasal washes from patients aged 6 weeks to 5 years who developed lower respiratory tract illness using quantitative real-time PCR for WU and KI. We collected data regarding presenting symptoms, signs, radiographic findings, laboratory data and coinfection. Results: The prevalence and co-infection rates for WU were 5.3% and 74% respectively and 4.2% and 84% respectively for KI. Higher KI viral loads were observed in patients with severe or very severe pneumonia, those presenting with chest indrawing, hypoxia without wheeze, convulsions, and with KI monoinfection compared with co-infection. There was no significant association between viral load and clinical presentation for WU. Conclusions: These findings suggest a potential pathogenic role for KI, and that there is an association between KI viral load and illness severity.
Background
WU and KI are small, icosahedral, non-enveloped doublestranded deoxyribonucleic acid (DNA) viruses [1] in the family Polyomaviridae. They were discovered in 2007 in the respiratory tract of children and adults, begging the question of their contribution to respiratory tract infections (RTI). Since their initial discovery, they have been detected in respiratory specimens worldwide [2] [3] [4] [5] [6] [7] . Children appear to have higher detection rates in the respiratory tract than adults, with the highest rates (up to 13%) in 1-2 year olds [8] [9] [10] . The clinical presentation in persons with specimens positive for either KI or WU appears to be similar to other respiratory viruses, and includes fever, cough, and other upper and lower respiratory symptoms [5, 8, 10] . However, complete clinical characteristics including radiographic and laboratory findings have not been well defined for these viruses.
Controversy persists as to whether WU and KI are true respiratory pathogens. KI and WU have been identified as the sole pathogens in respiratory tract specimens that have undergone wide screening for other viruses, bacteria and fungi. There is, however, a high co-detection rate with other respiratory viruses; 31-79% for WU, and 33-74% for KI [10] [11] [12] . Furthermore, WU has been found in the respiratory tract of asymptomatic patients. Studies have detected viral sequences at similar or higher frequencies in asymptomatic patients [3, 4, 13] , but few studies exist for KI.
Several real-time PCR methods have been developed for detecting both viruses [14] [15] [16] , which offer higher sensitivity and specificity than traditional PCR. Quantitative real-time PCRs have recently been used to define the role of respiratory viruses such as RSV and bocavirus [17, 18] , and may contribute to further understanding the epidemiological and clinical impact of WU and KI. Quantitative PCR has been developed for WU, and studies report low viral loads in subjects with RTIs [19] , with no correlation between viral load and clinical severity [6] . Their implementation for the study of KI, however, has been more limited, and the significance of viral load for KI, and correlation with illness severity, remain unknown.
Objectives
In order to further characterize the clinical presentation of these viruses, we sought to 1) determine the presence of WU and KI among children with lower respiratory tract infection, 2) describe their clinical features in more detail than previously reported, and 3) determine whether viral load correlates with illness severity.
Study design

Study population
From 2000 to 2004, a cohort of 12,194 children less than 2 years of age were enrolled in a randomized, placebo-controlled, double-blinded trial testing the efficacy of an 11-valent pneumococcal conjugate vaccine (11 PCV) in 6 barangays (villages) in Bohol, Philippines [20] . Concurrently, all children from the 6 barangays who were 5 years of age or less, who were not in the trial, and who were admitted to the hospital or who visited the outpatient department of the Bohol Regional Hospital were enrolled in a separate prospective epidemiologic study (the EpiGreyStudy). Hospitalized and outpatient subjects in the EpiGreyStudy were examined, treated and investigated exactly the same as those in the vaccine trial. Nasal wash specimens and sera were collected from all patients hospitalized with lower respiratory infection (LRI), and one in 5 outpatients with LRI, within two years of enrolment or by the end of study follow-up at the end of December 2004. The protocol included a blood culture and chest x-ray for all episodes, and CSF culture when indicated.
In these 2 groups of subjects, 5570 clinical episodes of LRI were observed, and 2066 nasal washes were obtained as described previously [21] . Data regarding hospital admissions and other important medical events were collected until the end of the study or study follow-up.
Definitions and clinical characteristics
An LRI was defined as the presence of lower respiratory tract signs (crackles, wheezing or bronchial breathing) in children with cough or difficulty breathing, or the presence of WHO-defined pneumonia [22] or radiographic pneumonia. Clinical pneumonia was classified using World Health Organization (WHO) severity grades as non-severe, severe and very severe in infants and children with cough and/or difficulty breathing. Fast breathing (respiratory rate ≥ 60/min if age <2 months, ≥ 50/min if age 2-11 months and ≥40/min if age 12-59 months) identified non-severe pneumonia; lower chest-wall indrawing defined severe pneumonia, and cyanosis, the inability to feed or drink and convulsions were the features of very severe pneumonia [23] . Other detailed information collected for the study included presenting symptoms, vital signs, physical examination findings, radiographic findings and laboratory data.
Pathogen detection
Samples were screened by Quantitative Real-Time PCR for the presence of WU and KI. The method for Quantitative Real-Time PCR, including the primer and probe sequences, has been described previously [24] . Briefly, viral nucleic acids were extracted from the respiratory specimens using the TRIzol ® extraction method (Invitrogen, Camarillo, CA), following the manufacturer's instructions. The DNA primers and probes for the VP1 region of WU and KI were designed using Primer Express software 3.0 (Applied Biosystems, Foster City, CA). Basic Local Alignment Search Tool (BLAST) searching of the primer and probe sequences found the sequences to be specific to WU and KI, and control PCR reactions with other polyomavirus VP1 sequences (BK Virus, JC Virus, Simian Virus 40 (SV40), lymphotrophic polyomavirus (LPV), Merkel cell virus (MCV)) confirmed this analysis. Quantitative real-time PCR was performed on the ABI Prism ® 7750 Sequence Detector. All real-time assays used previously described PCR buffer and cycling conditions [24] . Results initially expressed as cycle threshold (Ct), were converted to copy number by creating a standard curve using serial dilutions of a control plasmid of known concentration. Viral copy numbers were normalized to human cells in the specimen using the C-reactive protein (CRP) copy number, and were expressed as copies per mL of sample and copies per cell.
Specimens were previously tested for the presence of other respiratory viruses including respiratory syncytial virus (RSV), influenza, parainfluenza, human metapneumovirus (hMPV) and rhinovirus using routine respiratory tissue culture, conventional respiratory shell vial culture, and the PLx Multi-Code Respiratory Virus Panel (PLx-RVP), manufactured by Eragen Biosciences, Inc. (Madison, WI). The methods for testing followed the standard protocols and have been described previously [21] .
Statistical analysis
We estimated that with a sample of 1200 individuals, we would be able to construct a 95% confidence interval around the proportion of WU and KI positive specimens with a precision of 0.03, assuming a baseline rate for both KI and WU to be 0.50. Demographic and clinical features were compared between WU or KI-infected and non-infected children. In addition, for those who tested positive, comparisons were made between WU or KI as the sole virus detected and WU or KI co-detected with other respiratory viral and invasive bacterial pathogens. Categorical variables were compared using the chi-square test or Fisher's exact test for association. Continuous variables with non-normal distributions were compared using the Mann Whitney U test. All comparisons were two-sided and a P value of <0.05 was considered significant. All statistical analyses were performed using SPSS (SPSS, Inc., v.21, IBM) and SAS version 9.0 (SAS Institute Inc., Cary, NC). 
Results
Among 1269 respiratory specimens available, 1119 had sufficient DNA present for PCR testing after extraction, representing 1013 patients. Of these, 1077 were positive for CRP (used as the internal control) and were simultaneously tested for the presence of WU and KI. The child years of observation was 357.1 for children aged 6 months to <1 year, and 644.5 for children aged 1-2 years. Child years of observation data was not available for children >2years of age as the EpiGreyStudy patients were not in a population-based cohort.
KI was present in 45/1077 (4.2%) specimens. The median age of infection was 13.9 months. The seasonality of KI is shown in Fig. 1 . The co-detection rate with other respiratory viruses was 84%. There was a significantly higher rate of monoinfection with KI in children 24-59 months of age, compared to those <24 months (P = 0.0123). The cumulative age distribution for KI is shown in Fig. 2 .
The clinical characteristics of children with single KI infections compared to those co-infected with other respiratory viruses are outlined in Table 1 . While the clinical presentation, radiographic and laboratory findings were identical, significantly more children with KI mono-infection had convulsions compared with those with co-infections. CSF cell count and biochemistry from these children were normal and bacteriologically sterile.
Subsequent univariate analyses comparing sole infection with KI versus KI with parainfluenza, influenza, and hMPV, showed no difference in clinical, radiologic or laboratory parameters. However when compared with RSV co-infection, patients with KI sole infection were less likely to present with very severe pneumonia (0% vs 18%, P = 0.041), have tachypnea (33% vs 91%, P = 0.013), and when compared to co-infection with rhinovirus, were less likely to present with wheezing (0% versus 47%, P = 0.037).
We explored viral loads with regards to clinical presentation, and compared sole infection versus co-infections. The geometric mean (GM) viral load for KI was 1.05 × 10 6 copies/cell, (4.6 × 10 11 copies/mL). A higher viral load was associated with KI monoinfection compared with co-infection ( Fig. 3 ). In addition, there was a higher KI viral load among patients with chest indrawing, hypoxia in the absence of wheeze, and convulsions, compared to patients without these findings (Fig. 4) . We also observed a significantly higher viral load for KI among patients with severe or very severe pneumonia compared with no or non-severe pneumonia (Fig. 5 ). Viral loads are presented as copies per cell and copies per mL in Table 2 , online.
WU virus was detected in 57/1077 (5.3%) specimens. The median age of infection was 13.7 months for WU. The seasonality and cumulative age distributions of WU are shown in Figs. 1 and 2 respectively. Most cases occurred from June to October, similar to KI, coinciding with the rainy seasons. The cumulative age distribution of WU parallels the distributions of KI and RSV, with most infection occurring by 36 months of age. Co-detection with other respiratory viruses was 74%, slightly lower than KI. The clinical characteristics of monoinfection and coinfection were similar, as shown in Table 1 . The GM viral load for WU was 9.74 × 10 7 copies/cell, (GM 9.07 × 10 12 copies/mL). There was no significant association between viral load and clinical presentation (Figs. 4 and 5 and Table 2 , online).
Discussion
In contrast to previous associations with milder disease, KI was detected in the respiratory tract of children with severe and very severe lower respiratory tract illness, in the absence of other respiratory viruses and bacteria. In addition, there was a higher KI viral load among patients presenting with chest indrawing, hypoxia in the absence of wheeze, convulsions, severe and very severe pneumonia, as well as monoinfection compared with coinfection. While there were no unique clinical features associated with WU and KI monoinfection, we found that there was a higher proportion of children presenting with convulsions among those with KI monoinfection. These findings suggest a potential role for KI causing respiratory tract illness, and that there is an association between KI viral load and illness severity. Preliminary studies have led to the hypothesis that WU and KI may have an etiological role in respiratory illness, particularly in children and immunocompromised adults [2, 4, 5, [25] [26] [27] . However, these studies remain speculative due to the high codetection rates of other viruses and bacteria observed with WU and KI, which was also observed in our study. While our study and others detect these viruses in patients with LRTI even in the absence of other pathogens, these findings alone cannot implicate them as true respiratory pathogens.
We propose a possible pathogenic role for KI not merely due to its presence in the respiratory tract of children with LRTI, but because of associations between viral load and illness severity. Due to high co-detection rates of WU and KI and lack of asymptomatic controls in our study, we performed quantitative PCR to determine whether significant levels were present in patients presenting with LRTI, and whether it could provide a correlate for illness severity. A relationship between viral load and illness severity has been shown to be the case for some viruses, such as RSV and bocavirus [17, 18] , but not for others, such as rhinovirus [28] . The viral load of KI was similar to findings in our prior study among children presenting with respiratory tract illness, but lower than in symptomatic hematology/oncology patients [24] . A relationship between illness severity and viral load was observed for KI, as there was a higher viral load seen in patients with severe or very severe pneumonia versus no or non-severe pneumonia. While this association may be related to the more severe underlying disease of these patients, we also found higher viral load associated with chest indrawing, hypoxia in the absence of wheeze and convulsions. Therefore, this study suggests that viral load may correlate with illness severity for KI. However, a factor limiting further conclusions about the pathogenic plausibility of KI in our study is the high co-detection rate and small number of patients with KI monoinfection. The reported prevalence of WU and KI varies in the literature depending on the geographic location and population studied. The rates of WU observed in our study were slightly lower than in some published studies in children 7% reported in children in Connecticut [13] , 13.9% in children in Japan [29] , 7% in HIV exposed children in South Africa [30] , but other studies report even lower prevalence (0.4% in children in Germany [31] , 2% in children in Sweden [12] ). We found a slightly higher incidence of KI in children in our study than other pediatric reports in the literature: 2.8% in St Louis [32] , 0.9% in Germany [31] , 2.2% in Connecticut [13] , 1.4% in Japan [29] , and 1% in HIV exposed children in South Africa [30] . However, rates of up to 8% have been reported in France [27] .
KI monoinfection was not associated with any distinctive respiratory features, but there were higher rates of patients presenting with convulsions. While these findings may be the product of chance, we also found that the viral load was significantly higher among patients with convulsions compared with those without convulsions. The significance of this finding is unknown. WU and KI have not been associated with neurological disease such as meningitis or encephalitis. They have been detected with varying frequency in the brain tissue of immunocompromised and immunocompetent patients previously [25, 33] , and may exhibit similar tissue tropism to JC virus, which is known to reactivate in immunosuppressed individuals and cause progressive multifocal leukoencephalopathy. KI has not been detected in the CSF from pediatric patients, unlike WU [34, 35] . Our patients with convulsions and KI monoinfection did not have evidence of meningitis based on presentation, CSF cell counts and bacterial cultures. Our findings therefore raise the question of whether there is an increase in febrile seizure risk in patients with KI monoinfection, which warrants further study.
We accept that at there are several limitations of the use of quantitative PCR for WU and KI detection. These include the lack of a clear clinically relevant cutoff value, and the potential variability in viral load depending on the type of respiratory specimen collected and sampling method. Sample quality is paramount for the detection and quantification of respiratory viruses. The quality of nasal wash samples can vary due to specimen collection methods and sample dilution. Furthermore, studies have indicated variability in respiratory viral detection and quantification depending on the sample type and technique [36] [37] [38] . This variability has been highlighted in a study of multiple respiratory viruses from paired respiratory samples. The study demonstrated that WU and KI were more likely to be detected from nasopharyngeal aspirates than bronchoalveolar lavages [39] , highlighting the importance of proper sampling and the need for standardized procedures. Therefore, accepting some potential variability based on specimen type and collection methods, the use of viral load measurement to assess illness severity warrants further study.
While there were several intriguing findings for KI, we were unable to find similar correlations for WU with respect to monoinfection, and relationship between clinical severity and viral load, similar to results reported by Neske et al. [6] . Given our findings, and the frequent presence of WU in asymptomatic individuals, the link between WU and respiratory tract illness remains speculative.
One of the study's strengths lies in the cohort used. Data was obtained from a large population-based study, with detailed and standardized data collection methods (symptoms, signs, laboratory and chest x-ray findings). Thus, a more complete description of the clinical characteristics associated with WU and KI could be collected, and a reliable classification for the severity of illness was possible. In addition, our study comprised a large cohort of pediatric patients tested for the presence of other respiratory pathogens, enabling us to study the clinical characteristics of monoinfection versus co-infection. However, we accept that there may be other viral and bacterial pathogens causing pneumonia that were not detected by the testing methods used in the study.
Conclusions
In conclusion, our study of WU and KI among Filipino children under 5 years of age with LRTI suggests a potential pathogenic role for KI. We detected higher KI viral loads among patients with more severe illness, and found higher rates of convulsions and higher viral loads in patients with KI monoinfection. No such associations were observed for WU. However, due to low prevalence and high co-detection rates of these viruses, further study is required to determine their clinical significance.
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